Visual Detox 6037

Active substance: TAURINE, ZEAXANTHIN, BOS TAURUS EYE, GLUTATHIONE, GERMANIUM, GRAPHITE, SEPIA OFFICINALIS JUICE, BILBERRY, HUMAN ADENOVIRUS B SEROTYPE 3, CARBON DISULFIDE, CHLAMYDIA TRACHOMATIS, CHLOROQUINE, HUMAN HERPESVIRUS 1, INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), GONORRHEAL URETHRAL SECRETION HUMAN, NAJA NAJA VENOM, NAPHTHALENE, STAPHYLOCOCCUS AUREUS

LIQUID · TAURINE 6 [hp_X]/59mL, ZEAXANTHIN 6 [hp_X]/59mL, BOS TAURUS EYE 6 [hp_X]/59mL, GLUTATHIONE 8 [hp_X]/59mL, GERMANIUM 9 [hp_X]/59mL, GRAPHITE 12 [hp_X]/59mL, SEPIA OFFICINALIS JUICE 12 [hp_X]/59mL, BILBERRY 12 [hp_X]/59mL, HUMAN ADENOVIRUS B SEROTYPE 3 30 [hp_X]/59mL, CARBON DISULFIDE 30 [hp_X]/59mL, CHLAMYDIA TRACHOMATIS 30 [hp_X]/59mL, CHLOROQUINE 30 [hp_X]/59mL, HUMAN HERPESVIRUS 1 30 [hp_X]/59mL, INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL, GONORRHEAL URETHRAL SECRETION HUMAN 30 [hp_X]/59mL, NAJA NAJA VENOM 30 [hp_X]/59mL, NAPHTHALENE 30 [hp_X]/59mL, STAPHYLOCOCCUS AUREUS 30 [hp_X]/59mL

United StatesActive

Marketing holder: Professional Complementary Health Formulas

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

TAURINE · 6 [hp_X]/59mL
ZEAXANTHIN · 6 [hp_X]/59mL
BOS TAURUS EYE · 6 [hp_X]/59mL
GLUTATHIONE · 8 [hp_X]/59mL
GERMANIUM · 9 [hp_X]/59mL
GRAPHITE · 12 [hp_X]/59mL
SEPIA OFFICINALIS JUICE · 12 [hp_X]/59mL
BILBERRY · 12 [hp_X]/59mL
HUMAN ADENOVIRUS B SEROTYPE 3 · 30 [hp_X]/59mL
CARBON DISULFIDE · 30 [hp_X]/59mL
CHLAMYDIA TRACHOMATIS · 30 [hp_X]/59mL
CHLOROQUINE · 30 [hp_X]/59mL
HUMAN HERPESVIRUS 1 · 30 [hp_X]/59mL
INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) · 30 [hp_X]/59mL
GONORRHEAL URETHRAL SECRETION HUMAN · 30 [hp_X]/59mL
NAJA NAJA VENOM · 30 [hp_X]/59mL
NAPHTHALENE · 30 [hp_X]/59mL
STAPHYLOCOCCUS AUREUS · 30 [hp_X]/59mL

Products containing taurine in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
RU 63	ГЕНФЕРОН® суппозитории вагинальные и ректальные, 55 мг+500000 МЕ+10 мг (original in Russian, GRLS) ЛП-№(000124)-(РГ-RU) Акционерное общество "БИОКАД" (АО "БИОКАД") ГЕНФЕРОН® ЛАЙТ суппозитории вагинальные и ректальные, 125000 МЕ+5 мг (original in Russian, GRLS) ЛП-№(007484)-(РГ-RU) Акционерное общество "БИОКАД" (АО "БИОКАД") ГЕНФЕРОН® ЛАЙТ спрей назальный дозированный, 50000 МЕ/доза+1 мг/доза, (100 доз) (original in Russian, GRLS) ЛП-№(007682)-(РГ-RU) Акционерное общество "БИОКАД" (АО "БИОКАД") ГЕНФЕРОН® ЛАЙТ капли назальные, 10000 МЕ/мл+0.8 мг/мл, 10 мл (original in Russian, GRLS) ЛП-№(008492)-(РГ-RU) Акционерное общество "БИОКАД" (АО "БИОКАД") ГЕНФЕРОН® ЛАЙТ капли назальные, 10000 МЕ/мл+0.8 мг/мл, 10 мл (original in Russian, GRLS) ЛП-002309 Акционерное общество "БИОКАД" (АО "БИОКАД") All products in this country (63)

Country

Products

RU 63

ГЕНФЕРОН®
суппозитории вагинальные и ректальные, 55 мг+500000 МЕ+10 мг (original in Russian, GRLS)
ЛП-№(000124)-(РГ-RU)
Акционерное общество "БИОКАД" (АО "БИОКАД")
ГЕНФЕРОН® ЛАЙТ
суппозитории вагинальные и ректальные, 125000 МЕ+5 мг (original in Russian, GRLS)
ЛП-№(007484)-(РГ-RU)
Акционерное общество "БИОКАД" (АО "БИОКАД")
ГЕНФЕРОН® ЛАЙТ
спрей назальный дозированный, 50000 МЕ/доза+1 мг/доза, (100 доз) (original in Russian, GRLS)
ЛП-№(007682)-(РГ-RU)
Акционерное общество "БИОКАД" (АО "БИОКАД")
ГЕНФЕРОН® ЛАЙТ
капли назальные, 10000 МЕ/мл+0.8 мг/мл, 10 мл (original in Russian, GRLS)
ЛП-№(008492)-(РГ-RU)
Акционерное общество "БИОКАД" (АО "БИОКАД")
ГЕНФЕРОН® ЛАЙТ
капли назальные, 10000 МЕ/мл+0.8 мг/мл, 10 мл (original in Russian, GRLS)
ЛП-002309
Акционерное общество "БИОКАД" (АО "БИОКАД")

All products in this country (63)

Registration

Registration number: 63083-6037
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 63083-6037 · Verified 2026-10-09 · open in source